ArticleTranslational andrology and urology2026
Intraoperative epididymal sperm cryopreservation during microsurgical vasoepididymostomy for obstructive azoospermia: intracytoplasmic sperm injection outcomes from a single-center cohort.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Microsurgical vasoepididymostomy (MVE) is employed as a therapeutic intervention for epididymal obstructive azoospermia (EOA). However, patency is not consistently attained. For such cases, intraoperative sperm cryopreservation during MVE may serve as an alternative strategy, potentially avoiding the need for subsequent surgical sperm retrieval procedures. This study aimed to evaluate the assisted reproductive technologies (ART) outcomes of cryopreserved epididymal sperm obtained during MVE compared to fresh ejaculated sperm and thawed testicular sperm. Methods: This retrospective study included 117 men diagnosed with obstructive azoospermia (OA) who underwent sperm cryopreservation from epididymal fluid or testicular tissue during MVE between November 2022 and July 2025. To evaluate the clinical utility of this strategy, two control groups were included: intracytoplasmic sperm injection (ICSI) cycles using fresh ejaculated sperm (fresh ejaculated group) and ICSI cycles using frozen-thawed testicular sperm from OA patients who underwent testicular sperm aspiration (TESA) (thawed TESA group). Results: Among the 117 patients who underwent MVE combined with sperm cryopreservation (comprising 73 cases of epididymal sperm and 44 cases of testicular sperm), 29 patients subsequently used their frozen epididymal sperm [thawed microsurgical vasoepididymostomy epididymal sperm (M-ES) group] while 6 patients used frozen testicular sperm for ART. Laboratory outcomes showed that the thawed M-ES group achieved comparable rates of fertilization (0.72±0.24 Conclusions: Cryopreserved epididymal sperm obtained during MVE achieved laboratory and clinical pregnancy outcomes comparable to fresh ejaculated sperm, supporting its preferential use over testicular sperm when epididymal sperm are available. These findings provide a rationale for routine epididymal sperm cryopreservation during MVE as a primary fertility preservation strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.